RMX-21399-35277
4 vaccinations
0 coded responses
3 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 946 / CA
- Registered
- 2022-09-15
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-26
Dose 2 — Pfizer-BioNTech
-
2021-11-26
Dose 3 — Pfizer-BioNTech
-
2022-09-14
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-15
Registered in v-safe
-
2022-09-15
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body achesAdult check-in
- 2022-12-14
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | No |
| 2 | 2021-03-26 | Pfizer-BioNTech | No |
| 3 | 2021-11-26 | Pfizer-BioNTech | No |
| 4 | 2022-09-14 | Pfizer-BioNTech | Flu |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.